INO Stock

Why Inovio Pharmaceuticals (INO) Stock Still Worth Watching In The Next Few Months?

Inovio Pharmaceuticals (NASDAQ: INO) stock did not continue to fall after it lost 25% of its price on April 23. That shows the thing is not too bad, right? Investors want to know more information about its vaccine development in order to make better decisions. - May 09, 2021

How To Trade Inovio Pharmaceuticals (INO) Stock After Losing Phase 3 Funds For COVID-19 Vaccine?

Inovio Pharmaceuticals (NASDAQ: INO) stock seems to have returned to a calm period now. The things may not be as bad as imaged when investors calm down and revalue the stock. - April 29, 2021

What's The Next For Inovio (INO) Stock After Announcing Plans For ex-US Global Phase 3 Trial for INO-4800?

I think that Inovio just lost some R&D funds, which doesn't mean it lost the U.S. market. - April 23, 2021

Inovio Pharmaceuticals (INO) 's COVID-19 Vaccine Is Still Worth To Expect

Results in new study showed INO-4800 induced a robust T cell response against all spike protein variants tested. - April 22, 2021

INO Stock: Why Is Inovio Pharmaceuticals Stock Undervalued?

INOVIO still has a chance and time to acquire success with INO-4800. - April 10, 2021

Vaxart or Inovio: Which Is More Likely to Double Your Money? | The Motley Fool

Let's look at what some of the smartest investors are saying. - March 21, 2021

What Are the Prospects for Inovio's COVID Vaccine? | The Motley Fool

The biotech could be a winner over the long run but faces some significant challenges. - March 14, 2021

Why MediciNova Stock Skyrocketed Today | The Motley Fool

The biotech announced a major new development partnership. - March 10, 2021

MNOV Stock: MediciNova Soars on Big BARDA Deal

MNOV stock is on the move after MediciNova shared that its MN-166 has received BARDA funding for repurposing research. - March 10, 2021

Sell INO stock While You Still Can

INO stock is poised to fall much further as the chances of a coronavirus vaccine approval fall and its competitors widen their lead. - March 08, 2021

Why Inovio Stock Is Tanking Today | The Motley Fool

Investors still appear to have doubts about two of the biotech's lead candidates. - March 02, 2021

Why Inovio's Positive Q4 Update Didn't Impress Investors | The Motley Fool

Better-than-expected top- and bottom-line results weren't enough. - March 02, 2021

Domino's Pizza Q4 Results Aren't as Spicy as Wall Street Hoped | The Motley Fool

The company may be seeing demand drop as the pandemic ebbs, one analyst says. - February 25, 2021

Are Short-Sellers Right About Inovio? | The Motley Fool

This straggler in the vaccine race is still facing some struggles -- but there are a couple of bright spots. - February 21, 2021

Domino's Pizza Earnings: 3 Trends to Watch | The Motley Fool

The pizza delivery leader reports earnings results in just a few days. - February 20, 2021

Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart | The Motley Fool

The choice isn't easy, but simplicity may be the answer. - February 15, 2021

INO Stock: Here's Why Inovio Is up More Than 20% - CNA Finance

INO stock is climbing in the market this morning as investors start to see the real value of DNA-based vaccines. - February 12, 2021

Why Inovio Pharmaceuticals Stock Is Soaring Today | The Motley Fool

An analyst is really bullish about the biotech stock. - February 12, 2021

Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock? | The Motley Fool

Once a leader in the COVID-19 vaccine race, does this biotech have what it takes to deliver market-shattering returns? - February 12, 2021

Better Buy: Domino's vs. DoorDash | The Motley Fool

Which stock will deliver a better return? - February 10, 2021

Is Now the Time to Buy Inovio Stock? | The Motley Fool

Reddit investors are sure hyped up about shares of this biotech underdog. Should you be as well? - February 07, 2021

Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake

Inovio soars Tuesday as retail investors take aim at the drugs industry. - February 02, 2021